WO1986003776A1 - Procede de preparation de cellules de plantes monocotyledones a transformation genetique stable - Google Patents
Procede de preparation de cellules de plantes monocotyledones a transformation genetique stable Download PDFInfo
- Publication number
- WO1986003776A1 WO1986003776A1 PCT/EP1985/000726 EP8500726W WO8603776A1 WO 1986003776 A1 WO1986003776 A1 WO 1986003776A1 EP 8500726 W EP8500726 W EP 8500726W WO 8603776 A1 WO8603776 A1 WO 8603776A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- plant cells
- plasmid
- process according
- dna
- hybrid
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 6
- 241000589158 Agrobacterium Species 0.000 claims abstract description 15
- 239000013600 plasmid vector Substances 0.000 claims abstract description 5
- 230000009466 transformation Effects 0.000 claims abstract description 5
- 241000196324 Embryophyta Species 0.000 claims description 71
- 239000013612 plasmid Substances 0.000 claims description 43
- 238000000034 method Methods 0.000 claims description 37
- 108090000623 proteins and genes Proteins 0.000 claims description 33
- 244000003416 Asparagus officinalis Species 0.000 claims description 10
- 241000589155 Agrobacterium tumefaciens Species 0.000 claims description 9
- 235000005340 Asparagus officinalis Nutrition 0.000 claims description 9
- 230000014509 gene expression Effects 0.000 claims description 8
- 241000234270 Amaryllidaceae Species 0.000 claims description 2
- 241000234280 Liliaceae Species 0.000 claims description 2
- 239000003550 marker Substances 0.000 claims description 2
- 241000234427 Asparagus Species 0.000 claims 1
- 241000234269 Liliales Species 0.000 claims 1
- 239000012634 fragment Substances 0.000 description 29
- 239000002609 medium Substances 0.000 description 29
- 238000012546 transfer Methods 0.000 description 17
- 108020004414 DNA Proteins 0.000 description 15
- LMKYZBGVKHTLTN-NKWVEPMBSA-N D-nopaline Chemical compound NC(=N)NCCC[C@@H](C(O)=O)N[C@@H](C(O)=O)CCC(O)=O LMKYZBGVKHTLTN-NKWVEPMBSA-N 0.000 description 10
- 229930027917 kanamycin Natural products 0.000 description 7
- 229960000318 kanamycin Drugs 0.000 description 7
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 7
- 229930182823 kanamycin A Natural products 0.000 description 7
- 108010058731 nopaline synthase Proteins 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 241001045988 Neogene Species 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 6
- GPRBEKHLDVQUJE-VINNURBNSA-N cefotaxime Chemical compound N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C(O)=O)=O)C(=O)/C(=N/OC)C1=CSC(N)=N1 GPRBEKHLDVQUJE-VINNURBNSA-N 0.000 description 6
- 101150091879 neo gene Proteins 0.000 description 6
- 239000013598 vector Substances 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- 108010066133 D-octopine dehydrogenase Proteins 0.000 description 5
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000010276 construction Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000010353 genetic engineering Methods 0.000 description 5
- PRPINYUDVPFIRX-UHFFFAOYSA-N 1-naphthaleneacetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 108010025815 Kanamycin Kinase Proteins 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 238000012217 deletion Methods 0.000 description 4
- 230000037430 deletion Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 230000010354 integration Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- IMXSCCDUAFEIOE-UHFFFAOYSA-N D-Octopin Natural products OC(=O)C(C)NC(C(O)=O)CCCN=C(N)N IMXSCCDUAFEIOE-UHFFFAOYSA-N 0.000 description 3
- IMXSCCDUAFEIOE-RITPCOANSA-N D-octopine Chemical compound [O-]C(=O)[C@@H](C)[NH2+][C@H](C([O-])=O)CCCNC(N)=[NH2+] IMXSCCDUAFEIOE-RITPCOANSA-N 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 206010020649 Hyperkeratosis Diseases 0.000 description 3
- 241000209510 Liliopsida Species 0.000 description 3
- 238000002105 Southern blotting Methods 0.000 description 3
- 229940088530 claforan Drugs 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 241001233957 eudicotyledons Species 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- OOYGSFOGFJDDHP-KMCOLRRFSA-N kanamycin A sulfate Chemical compound OS(O)(=O)=O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N OOYGSFOGFJDDHP-KMCOLRRFSA-N 0.000 description 3
- 229960002064 kanamycin sulfate Drugs 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 231100000590 oncogenic Toxicity 0.000 description 3
- 230000002246 oncogenic effect Effects 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 229910052902 vermiculite Inorganic materials 0.000 description 3
- 239000010455 vermiculite Substances 0.000 description 3
- 235000019354 vermiculite Nutrition 0.000 description 3
- 108091026890 Coding region Proteins 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 230000003816 axenic effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 239000003337 fertilizer Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000001338 necrotic effect Effects 0.000 description 2
- 231100001222 nononcogenic Toxicity 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 230000008488 polyadenylation Effects 0.000 description 2
- 230000002062 proliferating effect Effects 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 229910021653 sulphate ion Inorganic materials 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000008399 tap water Substances 0.000 description 2
- 235000020679 tap water Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- KUAZQDVKQLNFPE-UHFFFAOYSA-N thiram Chemical compound CN(C)C(=S)SSC(=S)N(C)C KUAZQDVKQLNFPE-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- HCWLJSDMOMMDRF-SZWOQXJISA-N 3-[(3s,6r)-2-oxo-6-[(1s,2r,3r)-1,2,3,4-tetrahydroxybutyl]morpholin-3-yl]propanamide Chemical compound NC(=O)CC[C@@H]1NC[C@H]([C@@H](O)[C@H](O)[C@H](O)CO)OC1=O HCWLJSDMOMMDRF-SZWOQXJISA-N 0.000 description 1
- ILQOASSPNGAIBC-UHFFFAOYSA-N Agropine Natural products OC(O)C(O)CC(O)C1CN2C(CCC2=O)C(=O)O1 ILQOASSPNGAIBC-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 108700003861 Dominant Genes Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 241000208133 Nicotiana plumbaginifolia Species 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- 241001672648 Vieira Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008238 biochemical pathway Effects 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229960003669 carbenicillin Drugs 0.000 description 1
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- JTEDVYBZBROSJT-UHFFFAOYSA-N indole-3-butyric acid Chemical compound C1=CC=C2C(CCCC(=O)O)=CNC2=C1 JTEDVYBZBROSJT-UHFFFAOYSA-N 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 230000000869 mutational effect Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000026267 regulation of growth Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 244000000000 soil microbiome Species 0.000 description 1
- 230000010473 stable expression Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 229960002447 thiram Drugs 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000005740 tumor formation Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
- C12N15/8205—Agrobacterium mediated transformation
Definitions
- Ti-piasmids still contain the border sequences and consequently transfer T-DNA without tumor induction.
- An example of such a Ti-plasmid derived vector for plant engineering is pGV 3850.
- This Ti-derivative has proven very useful. It contains a substitution of the internal T-DNA genes by the commonly used cloning vehicle pBR322. Plant cells transformed by pGV 3850 have the same regenerative capacity as untransformed cells and several procedures have been developped to obtain intact plants which contain the pGV 3850 T-DNA.
- pGV 3850, through the pBR 322 sequences present in its T-DNA, is an efficient acceptor plasmid for gene transfer experiments in plant cells (see European patent application No. 0 116 718).
- genes cloned in pBR 322-like plasmids are transfered to Agrobacterium and inserted via homologous recombination into the pGV 3850 T-DNA in a single experimental step.
- Another major advance in the application of T-DNA as a vector is the use of plant regulatory sequences to express chimeric genes in plants.
- These chimeric genes contain a promotor region derived from a gene which is naturally expressed in plant cells, the sequence to be expressed, and preferentially a 3'-non-translated region containing a poly-adenylation site of a gene which is naturally expressed in plant cells.
- a promotor region derived from a gene which is naturally expressed in plant cells
- the sequence to be expressed and preferentially a 3'-non-translated region containing a poly-adenylation site of a gene which is naturally expressed in plant cells.
- dominant selectable markers for plant cells have been constructed.
- the genes involved in the synthesis of opines are encoded by the T-DNA of Agrobacterium, but the regulatory sequences involved in their expression are of an eucaryotic type. This explains why these genes are expressed in a plant environment.
- the observation of the presence of opines in the wound tissue of infected monocotyledonous plants suggested at least a temporarily transfer and expression of Ti-plasmid genes into the monocotyledonous plant.
- these data did not provide any prove for stable transfer of Ti- plasmid DNA into the plant cell. The investigators did not show the monocot tissue to produce opines after sub-culture under aseptical conditions.
- the object of the invention is to provide a process for preparing transformed monocotyledonous plant cells which are genetically stable.
- a further object of the invention is the preparation of genetically transformed monocotyledonous plant cells as well as plants regenerated therefrom.
- the present invention relates to a process for preparing transformed plant cells which are genetically stable comprising the transformation of plant cells using Agrobacterium harbouring a hybrid Ti-plasmid vector, characterized in that the plant cells are derived from a monocotyledonous plant.
- the invention makes use of hybrid Ti-plasmids such as those described in European Patent Application No. 0116718. These are Ti-plasmids, from which the oncogenic genes or tumor inducing genes have been removed from the T-DNA.
- Ti-plasmids can be used which contain a gene of interest operatively linked to a suitable oromoter, e.g. the nopaline-synthase-promoter. Such a combination is also called a chimeric gene.
- these plasmids contain chimeric antibiotic resistance genes, which provide a dominant selectable marker for plant cells.
- Fig. 1 Construction of the intermediate plasmid vector pLGVneo1103. a
- Step 1 Construction of/290 bp Sau 3A fragment containing the nopaline synthase promoter.
- the construction is similar to the one described bv Herrera- Estrella et al. (ref. 2 ) .
- the starting plasmid is PLGV13 (ref.2). 20 ⁇ g of pLGV13
- T4 DNA ligase (Biolabs, New England) with 2 units T4 DNA ligase in a total volume of 20 ⁇ l. After the T4 ligase was inactivated at 68° C for 10 minutes, each ligation mix was digested with 20 units BglII for 1 h at 37° C. Subsequently,
- DNA 50 ng DNA were recircularized with 0.1 unit T4/ligase in a total volume of 100 ⁇ l for 20 h at 4° C.
- T4/ligase 0.1 unit T4/ligase in a total volume of 100 ⁇ l for 20 h at 4° C.
- One fifth of this ligation mixture was transformed into competent
- E. coli K 514 cells (ref. 3 ) as described by Dagert and
- deletion end points in the plasmids were first analyzed by measuring the size of the newly generated Bcll-Bglll fragments of the recombinant plasmids. The nucleotide sequence of the exact deletion end points in some plasmids were determined.
- the nos promoter can be isolated as a
- Step 2 Insertion of Pnos in front of the neo gene.
- the 290 bp Bcll-Bglll fragment containing the nopaline synthase promoter (Pnos) was purified from a 2 % agarose gel by electroelution and inserted into pKM109-2 (ref. 7 ) .
- One of the resulting recombinants, pLGVneo011 contains the Pnos fragment in the orientation such that it will direct transcription of the neomycin phosphotransferase gene (neo) in plant cells.
- the orientation was determined by SacII-EcoRI digestion.
- Step 3 Insertion of the 3' end of the octopine synthase gene behind the neo gene.
- a fragment containing the 3' untranslated region of the octopine synthase gene was isolated from pGV99 (ref. 8 )) . This was achieved by digesting 20 ⁇ g of pGV99 DNA with 20 units of PvuII for 1 h at 37° C, separation of the fragments on a 0.8 % agarose gel and isolation of the 706 bp PvuII fragment by electroelution. The 706 bp PvuII fragment was inserted into the Smal site of pLGVneo011. One of the resulting recombinant plasmids, pLGVneo11 contains the PvuII fragment in the correct orientation with respect to the neo gene.
- pLGVneo1103 contains a chimeric neo gene consisting of the nopaline synthase promoter, the coding region of the neo gene and the 3' end of the octopine synthase gene, including the polyadenylation signal. The advantage of this chimeric neo gene over the one previously described (ref.
- the AUG initiation codon for the neomycin phosphotransferase is the first AUG codon in the 5' end of the transcript. This allows optimal translation to occur, and hence to provide resistance levels in plants towards Kanamycin, which are substantially higher
- Fig. 2 Schematic representation of the T region of PGV3850 and of intermediate vector PLGV1103. Tne crossed lines indicate the regions which were involved in co-integration of PGV3850 with pLGVneo1103. The T region of hybrid Ti-plasmid pGV2302 is represented.
- Ap,KM gene encoding resp. ampicillin and kanamycin resistance
- Fig. 3 Detection of nopaline in tissue extracts
- Example 1 Isolation of a cell culture line which is derived from a monocotyledonous plant and that contains and expresses T-DNA genes of Agrobacterium tumefaciens.
- Plant cells of Asparagus officinalis L.cv. (Ruhm v. Braunschweig) transformed with an oncogenic Ti-plasmid (e.g. C58) were prepared.
- the procedure involves the following steps:
- steps 1 to 10 Using this procedure (steps 1 to 10), a tissue culture line which grows vigorously on hormone-free media was obtained. Testing for nopaline in this tissue as described (steps 11 - 16) shows that it indeed produces significant levels of nopaline (see Fig. 3). It was concluded that T-DNA promoters are active in these cells, with an efficiency comparable to that found in dicots . Genes for hormone independent growth are also expressed since the transformed cells proliferate on hormone free culture medium. The presence of T-DNA in the transformed cell line was further demonstrated by Southern blot analysis of total DNA established from the cell cultures, using cloned T-DNA fragments as radioactive probes. The procedure involves the following steps:
- Plant cells of Asparagus officinalis L. cv. "Ruhm v. Braunschweig” transformed with a non-oncogenic Ti-plasmid derivative (eg. pGV2302) were prepared.
- the hybrid Ti-plasmid used in this experiment and carrying a gene of interest was pGV2302.
- This plasmid is a derivative of pGV3850 which is described in European Patent Application No. 0116718 and was obtained as follows. According to the method of Van Haute et al. (ref. 11) helper plasmids were transferred from GJ23 cells to E. coli K514r-m + containing pGLVneo1103 (for detailed description see below).
- pGLVneo1103 can also be transferred to the helper plasmid containing GJ23 cells.
- pGLVneo1103 is mobilized during conjugation from the bacteria strain containing the helper plasmids as well as pGLVneo 1103 to Agrobacterium tumefaciens C 58 C 1 Rif R pGV3850 which carries the hybrid Ti-plasmid pGV3850 (ref. 18). This plasmid transfer is followed by an in vivo recombination event in the recipient strain of Agrobacterium tumefaciens.
- the result is the recombinant plasmid pGV2302 which carries the genetic information for rifampycin and kanamycin resistance (see Fig. 2) .
- the strain C 58 C 1 Rif R pGV2302 of Agrobacterium tumefaciens carrying plasmid pGV2302 and the strain of E. coli carrying the plasmid pGLVneo1103 were deposited with the Deutsche Sammlung fiir Mikroorganismen, Göttingen, West Germany, under the accession numbers DSM 3168 and DSM 3169, respectively.
- pLGVneo1103 (a detailed description of the construction is given in Fig. 1) is an intermediate vector which contains a chimeric gene consisting of the promoter of the nopaline synthase gene (Depicker et al., ref. 14 ), the coding region of the neomycin phosphotransferase gene of Tn5, and the 3' terminal sequences of the octopine synthase gene (Dhaese et al., ref. 1 5 ).
- the procedure involves the following steps:
- the calli are about 1 cm in diameter. Devide the calli in pieces of approx. 5 mm diameter and transfer them in 5 cm petridishes containing LS medium with 1 mg/1 BAP, 1 mg/1 NAA, 200 mg/1 glutamine, 250 mg/1 cefotaximum, and 50 mg/1 kanamycin sulfate (Sigma). Use one dish per original callus. Kanamycin sulfate was prepared as a stock solution at 50 mg/ml in distilled water and the pH was adjusted to 5,7 with HCl. The solution was filter-sterilized. The pH of the medium at the moment of its use was 5.7.
- steps 1 - 11 2 independent tissue culture lines which grow vigorously on media containing 50 mg/1 kanamycin sulfate were obtained. Testing for nopaline in these tissues as described (steps 12 - 17) indicated that both of them indeed produce significant levels of nopaline (see Fig. 3).
- kanamycin resistant and nopaline containing plants were regenerated from two of the transformed asparagus plants and transferred to the greenhouse.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Procédé de préparation de cellules de plantes monocotylédones à transformation génétique stable, consistant à transformer les cellules monocotylédones en utilisant un Agrobactérium abritant un vecteur de Ti-plasmide hybride.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT84116036.9(EP) | 1984-12-21 | ||
EP84116036 | 1984-12-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1986003776A1 true WO1986003776A1 (fr) | 1986-07-03 |
Family
ID=8192377
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1985/000726 WO1986003776A1 (fr) | 1984-12-21 | 1985-12-20 | Procede de preparation de cellules de plantes monocotyledones a transformation genetique stable |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0205518A1 (fr) |
AU (1) | AU5309686A (fr) |
WO (1) | WO1986003776A1 (fr) |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0267159A3 (fr) * | 1986-11-07 | 1990-05-02 | Ciba-Geigy Ag | Procédé de modification génétique de monocotylédones |
WO1992014828A1 (fr) * | 1991-02-14 | 1992-09-03 | Svalöf Ab | Procede de transformation genetique d'organes tissulaires provenant de plantes monocotyledones |
US5595733A (en) * | 1987-05-20 | 1997-01-21 | Ciba-Geigy Corporation | Methods for protecting ZEA mays plants against pest damage |
US6040498A (en) * | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
WO2000058484A3 (fr) * | 1999-03-26 | 2001-01-18 | Univ Guelph | Transformation de plantes monocotyledones a l'aide d'agrobacterium |
US6664109B2 (en) | 1985-01-17 | 2003-12-16 | Calgene Llc | Transformation system with Ti or Ri plasmid |
US6946587B1 (en) | 1990-01-22 | 2005-09-20 | Dekalb Genetics Corporation | Method for preparing fertile transgenic corn plants |
US6960709B1 (en) | 1993-08-25 | 2005-11-01 | Dekalb Genetics Corporation | Method for altering the nutritional content of plant seed |
US7060876B2 (en) | 1992-07-07 | 2006-06-13 | Japan Tobacco Inc. | Method for transforming monocotyledons |
US7064248B2 (en) | 1990-01-22 | 2006-06-20 | Dekalb Genetics Corp. | Method of preparing fertile transgenic corn plants by microprojectile bombardment |
US7161064B2 (en) | 1997-08-12 | 2007-01-09 | North Carolina State University | Method for producing stably transformed duckweed using microprojectile bombardment |
US7615685B2 (en) | 1990-01-22 | 2009-11-10 | Dekalb Genetics Corporation | Methods of producing human or animal food from stably transformed, fertile maize plants |
WO2014153032A1 (fr) | 2013-03-14 | 2014-09-25 | Evolutionary Genomics, Inc. | Identification et utilisation de gènes de la tomate contrôlant la tolérance au sel/à la sécheresse et le goût sucré du fruit |
EP2927323A2 (fr) | 2011-04-11 | 2015-10-07 | Targeted Growth, Inc. | Identification et utilisation de mutants kpr dans des plantes |
EP3552482A1 (fr) | 2013-10-29 | 2019-10-16 | Biotech Institute, LLC | Sélection, production, traitement et utilisation de cannabis spécial |
US11530419B2 (en) | 2020-10-30 | 2022-12-20 | Fortiphyte, Inc. | Pathogen resistance in plants |
WO2024052856A1 (fr) | 2022-09-09 | 2024-03-14 | Friedrich Alexander Universität Erlangen-Nürnberg | Éléments régulateurs chez des plantes et leurs utilisations |
WO2025030048A2 (fr) | 2023-08-03 | 2025-02-06 | J.R. Simplot Company | Gènes de résistance aux fusarioses |
US12225874B2 (en) | 2023-03-27 | 2025-02-18 | Redsea Science And Technology Inc. | Tomato plant designated ‘X22-31’ |
WO2025046294A1 (fr) | 2023-08-29 | 2025-03-06 | University Of Freiburg | Protéines pour la régulation d'une infection symbiotique et éléments régulateurs associés |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1983001176A1 (fr) * | 1981-10-01 | 1983-04-14 | Int Plant Research Inst | Procede de modification genetique de cereales avec des vecteurs de transformation |
EP0159418A1 (fr) * | 1984-04-03 | 1985-10-30 | Rijksuniversiteit Leiden | Procédé pour l'incorporation D'ADN étranger dans le génome de plantes monocotylédones |
-
1985
- 1985-12-20 WO PCT/EP1985/000726 patent/WO1986003776A1/fr unknown
- 1985-12-20 EP EP19860900142 patent/EP0205518A1/fr not_active Withdrawn
- 1985-12-20 AU AU53096/86A patent/AU5309686A/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1983001176A1 (fr) * | 1981-10-01 | 1983-04-14 | Int Plant Research Inst | Procede de modification genetique de cereales avec des vecteurs de transformation |
EP0159418A1 (fr) * | 1984-04-03 | 1985-10-30 | Rijksuniversiteit Leiden | Procédé pour l'incorporation D'ADN étranger dans le génome de plantes monocotylédones |
Non-Patent Citations (6)
Title |
---|
Nature, Volume 311, 25 October 1984, No. 5988, Reading, Berks, (GB) G.M.S. HOOYKAAS-Van Slogteren et al.: "Expression of Ti Plasmid Genes in Monocotyledonous Plants Infected with Agrobacterium Tumefaciens", pages 763-764, see the whole document (cited in the application) * |
Nature, Volume 311, October 1984, No. 5988, Reading, Berks (GB) M.H. DRIMMOND: "Plant Engineering: More Prospects fo Ti Plasmids", page 706, see the whole article * |
Science, Volume 222, 18 November 1983, A. CAPLAN et al.: "Introduction of Genetic Material into Plant Cells", pages 815-821, see page 821, column 3, paragrah * |
The EMBO Journal, Volume 2, No. 12, 1983, P. ZAMBRYSKI et al.: "Ti Plasmid Vector for the Introduction of DNA into Plant Cells Without Alteration of their Normal Regeneration Capacity", pages 2143-2150, * |
The EMBO Journal, Volume 3, No. 12, 1984 J. VELTEN et al.: "Isoltion of a dual Plant Promoter Fragment from the Ti Plasmidof Agrobacterium Tumefaciens", pages 2723-2730, see page 2724, column 1, last paragraph - column 2, paragraph 1; figure 2; page 2726, column 1, paragraph 3;, page 2727, column 2, paragraph 1; page 2728, column 2, lines 27-31; page 2729, column 1, lines 16-33 * |
The EMBO Journal, Volume 3, No. 13, 1984, J.P. HERNALSTEENS et al.: "An Agrobacterium Transformed Cell Culture from the Monocot Asparagus Officinalis", pages 3079-3041, see the whole document * |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6664109B2 (en) | 1985-01-17 | 2003-12-16 | Calgene Llc | Transformation system with Ti or Ri plasmid |
EP0267159A3 (fr) * | 1986-11-07 | 1990-05-02 | Ciba-Geigy Ag | Procédé de modification génétique de monocotylédones |
US5766900A (en) * | 1987-05-20 | 1998-06-16 | Novartis Corporation | Method of regenerating fertile transgenic Zea mays plants from protoplasts |
US5824302A (en) * | 1987-05-20 | 1998-10-20 | Novartis Finance Corporation | Method of controlling insect larvae comprising feeding an insecticidal amount of a transgenic maize plant expressing a polypeptide having Bt-crystal protein toxic properties |
US5595733A (en) * | 1987-05-20 | 1997-01-21 | Ciba-Geigy Corporation | Methods for protecting ZEA mays plants against pest damage |
US7615685B2 (en) | 1990-01-22 | 2009-11-10 | Dekalb Genetics Corporation | Methods of producing human or animal food from stably transformed, fertile maize plants |
US6946587B1 (en) | 1990-01-22 | 2005-09-20 | Dekalb Genetics Corporation | Method for preparing fertile transgenic corn plants |
US7064248B2 (en) | 1990-01-22 | 2006-06-20 | Dekalb Genetics Corp. | Method of preparing fertile transgenic corn plants by microprojectile bombardment |
WO1992014828A1 (fr) * | 1991-02-14 | 1992-09-03 | Svalöf Ab | Procede de transformation genetique d'organes tissulaires provenant de plantes monocotyledones |
US7060876B2 (en) | 1992-07-07 | 2006-06-13 | Japan Tobacco Inc. | Method for transforming monocotyledons |
US6960709B1 (en) | 1993-08-25 | 2005-11-01 | Dekalb Genetics Corporation | Method for altering the nutritional content of plant seed |
US7547820B2 (en) | 1993-08-25 | 2009-06-16 | Dekalb Genetics Corporation | Method for altering the nutritional content of plant seed |
US7161064B2 (en) | 1997-08-12 | 2007-01-09 | North Carolina State University | Method for producing stably transformed duckweed using microprojectile bombardment |
US6040498A (en) * | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
WO2000058484A3 (fr) * | 1999-03-26 | 2001-01-18 | Univ Guelph | Transformation de plantes monocotyledones a l'aide d'agrobacterium |
EP2927323A2 (fr) | 2011-04-11 | 2015-10-07 | Targeted Growth, Inc. | Identification et utilisation de mutants kpr dans des plantes |
WO2014153032A1 (fr) | 2013-03-14 | 2014-09-25 | Evolutionary Genomics, Inc. | Identification et utilisation de gènes de la tomate contrôlant la tolérance au sel/à la sécheresse et le goût sucré du fruit |
EP3552482A1 (fr) | 2013-10-29 | 2019-10-16 | Biotech Institute, LLC | Sélection, production, traitement et utilisation de cannabis spécial |
US11530419B2 (en) | 2020-10-30 | 2022-12-20 | Fortiphyte, Inc. | Pathogen resistance in plants |
WO2024052856A1 (fr) | 2022-09-09 | 2024-03-14 | Friedrich Alexander Universität Erlangen-Nürnberg | Éléments régulateurs chez des plantes et leurs utilisations |
US12225874B2 (en) | 2023-03-27 | 2025-02-18 | Redsea Science And Technology Inc. | Tomato plant designated ‘X22-31’ |
US12239091B2 (en) | 2023-03-27 | 2025-03-04 | Redsea Science And Technology Inc. | Tomato plant designated ‘MX20-06’ |
WO2025030048A2 (fr) | 2023-08-03 | 2025-02-06 | J.R. Simplot Company | Gènes de résistance aux fusarioses |
WO2025046294A1 (fr) | 2023-08-29 | 2025-03-06 | University Of Freiburg | Protéines pour la régulation d'une infection symbiotique et éléments régulateurs associés |
Also Published As
Publication number | Publication date |
---|---|
AU5309686A (en) | 1986-07-22 |
EP0205518A1 (fr) | 1986-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU611652B2 (en) | Process for the genetic modification of monocotyledonous plants | |
US6051757A (en) | Regeneration of plants containing genetically engineered T-DNA | |
Cheng et al. | Production of fertile transgenic peanut (Arachis hypogaea L.) plants using Agrobacterium tumefaciens | |
WO1986003776A1 (fr) | Procede de preparation de cellules de plantes monocotyledones a transformation genetique stable | |
US5501967A (en) | Process for the site-directed integration of DNA into the genome of plants | |
US5569597A (en) | Methods of inserting viral DNA into plant material | |
AU559562B2 (en) | Genetically transformed plants | |
Phelep et al. | Transformation and regeneration of a nitrogen-fixing tree, Allocasuarina verticillata Lam. | |
US5149645A (en) | Process for introducing foreign DNA into the genome of plants | |
EP0116718B1 (fr) | Procédé pour l'introduction de gènes exprimables dans les génomes de cellules de plantes et souches d'agrobactérium contenant des vecteurs plasmidiques Ti-hybrides utilisables dans ce procédé | |
US5188958A (en) | Transformation and foreign gene expression in brassica species | |
DK173104B1 (da) | Vektorkombination, acceptor-Ti-plasmid, intermediær kloningsvektor, fremgangsmåde til fremstilling af et hybridt Ti-plasmid | |
Chabaud et al. | Parameters affecting the frequency of kanamycin resistant alfalfa obtained by Agrobacterium tumefaciens mediated transformation | |
US6376234B1 (en) | Method of inserting viral DNA into plant material | |
EP0270615B1 (fr) | TRANSFORMATION DE CULTURES DE CELLULES ET EXPRESSION D'UN GENE ETRANGER DANS DES ESPECES $i(BRASSICA) | |
US20120192318A1 (en) | Transformation system for Camelina sativa | |
Fári et al. | Agrobacterium mediated genetic transformation and plant regeneration via organogenesis and somatic embryogenesis from cotyledon leaves in eggplant (Solanum melongena L. cv.‘Kecskemeti lila’) | |
WO1984002919A1 (fr) | Plasmides de transformation de cellules vegetales | |
Thomas et al. | Genetic transformation of Medicago truncatula using Agrobacterium with genetically modified Ri and disarmed Ti plasmids | |
OA10607A (en) | Vector and methods for introducing at least two genes into a plant | |
US20090151023A1 (en) | Transformation system for Camelina sativa | |
Kiyokawa et al. | Genetic transformation of Begonia tuberhybrida by Ri rol genes | |
AU614727B2 (en) | DNA molecules coding for proteins targeted to plant cell walls | |
Tzfira et al. | Highly efficient transformation and regeneration of aspen plants through shoot-bud formation in root culture | |
Bonnard et al. | Nucleotide sequence, evolutionary origin and biological role of a rearranged cytokinin gene isolated from a wide host range biotype III Agrobacterium strain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU DK JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LU NL SE |